
CINTAS CORP
CTASNASDAQ🏆 #171 by market capEarnings Sep 22US Equity
$205.28▲ $2.61 (+1.27%)
Live1h—
24h▲ 1.3%
7d—
14d—
30d—
1y—
🏦Market Cap
$82.15B
Mid Cap
📈Revenue Growth (YoY)
+8.7%
Slowing
📊Gross Margin
50.4%
Healthy
💵FCF Margin
17.1%
Healthy
⚖️P/S Ratio
7.3x
Fair
Otter Score
64
Fair
📊
Analyst Ratings
Price
$205.28
Total
30
Raised
2
Lowered
4
Avg PT
$231.25
| Institution | Action | Rating | Date |
|---|---|---|---|
Baird | Reiterated | Outperform | 2026-07-16 |
RBC Capital | Reiterated | Sector Perform | 2026-07-16 |
Wells Fargo | Reiterated | Overweight | 2026-07-16 |
UBS | Reiterated | Buy | 2026-07-16 |
B of A Securities | Upgraded | Neutral → Buy | 2026-07-16 |
Truist Securities | Reiterated | Buy | 2026-06-15 |
Citigroup | Reiterated | Sell | 2026-03-31 |
Stifel | Reiterated | Hold | 2026-03-26 |
Morgan Stanley | Reiterated | Equal Weight | 2025-12-17 |
JP Morgan | Reiterated | Overweight | 2025-09-25 |
Goldman Sachs | Reiterated | Buy | 2025-07-02 |
Barclays | Reiterated | Overweight | 2024-09-27 |
Jefferies | Reiterated | Hold | 2024-09-26 |
CFRA | Reiterated | Strong Sell → Sell | 2024-09-12 |
Oppenheimer | Reiterated | Perform | 2024-04-01 |
Deutsche Bank | Reiterated | Hold | 2024-03-28 |
Argus Research | Reiterated | Buy | 2023-07-14 |
Credit Suisse | Reiterated | Neutral | 2021-07-16 |
William Blair | Downgraded | Outperform → Market Perform | 2020-04-06 |
Stifel Nicolaus | Reiterated | Hold | 2019-09-25 |
Nomura | Reiterated | Neutral | 2019-07-22 |
Bank of America | Upgraded | Neutral → Buy | 2019-01-03 |
Nomura Instinet | Downgraded | Buy → Neutral | 2017-06-27 |
Instinet | Downgraded | Buy → Neutral | 2017-06-27 |
Keybanc | Reiterated | Overweight | 2016-10-03 |
KeyBanc | Reiterated | Overweight | 2016-10-03 |
Macquarie | Reiterated | Neutral | 2016-08-25 |
Sterne Agee CRT | Reiterated | Neutral | 2016-03-22 |
PiperJaffray | Reiterated | Neutral | 2013-11-18 |
Barrington Research | Downgraded | Outperform → Market Perform | 2012-07-17 |
One row per institution, most recent rating